Sign in
Back
Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline
Journal article   Peer reviewed

Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline

Ikbel Kooli, Hajer Ben Brahim, Mohamed Kilani, Chokri Gannouni, Abir Aouam, Adnene Toumi, Chawki Loussaief, Mohamed Nejib Hattab and Mohamed Chakroun
Journal of global antimicrobial resistance, Vol.5, pp.62-63
06/2016
DOI: https://doi.org/10.1016/j.jgar.2015.12.003
PMID: 27436468

Abstract

Acinetobacter baumannii - drug effects Acinetobacter Infections - drug therapy Adult Anti-Bacterial Agents - therapeutic use Colistin Drug Resistance, Multiple, Bacterial Humans Male Meningitis - drug therapy Meningitis - microbiology Microbial Sensitivity Tests Minocycline - analogs & derivatives Minocycline - therapeutic use Tigecycline
Tigecycline is a broad-spectrum antibiotic with activity against multidrug-resistant (MDR) bacteria. It has limited indications. Studies are necessary to elaborate new guidelines. Here we report a case of postoperative MDR Acinetobacter baumannii meningitis treated by tigecycline combined with colimycin for 21 days. The treatment was well tolerated with a favourable outcome. In conclusion, tigecycline was shown to be effective in a case of MDR A. baumannii meningitis.

Metrics

1 Record Views

Details